文献速递胸部技术与安全PETCT

FDG PET/CT肿瘤播散特征预测非小细胞肺癌一线全身治疗结局

FDG PET/CT Tumor Dissemination Characteristic Predicts the Outcome of First-Line Systemic Therapy in Non-small Cell Lung Cancer.
PubMed 文献 · Acad Radiol · 2023-05-16

本回顾性研究纳入101例接受一线全身治疗且基线有18F-FDG PET/CT图像的IV期非小细胞肺癌患者,以最远两病灶间距(Dmax)和全身肿瘤代谢体积(MTVwb)评估肿瘤播散与负荷。Dmax和MTVwb均为总生存期和无进展生存期的独立预后因素,二者联合可将患者分为0、1、2分三个风险组,分值越高生存越差。

要点

  • Dmax和MTVwb是IV期NSCLC一线治疗OS和PFS的独立预后因素。
  • MTVwb>54.0 cm3且Dmax>48.5 cm与更差PFS和OS相关(p=0.006和p=0.008)。
  • Dmax与MTVwb联合评分0、1、2分三组间PFS和OS差异显著(均p<0.001)。

核心结论

  • 肿瘤播散特征(Dmax)与肿瘤负荷(MTVwb)联合可进一步改善NSCLC的预后分层。

研究设计与样本

  • 回顾性研究,纳入101例接受一线全身治疗且基线有18F-FDG PET/CT图像的IV期非小细胞肺癌患者,计算Dmax、原发肿瘤MTV和全身肿瘤MTVwb,采用Kaplan-Meier生存分析和Cox预测模型评估参数与生存的关系。

诊断标准与关键数值

  • Dmax定义为距离最远的两个病灶之间的距离;MTVwb为全身肿瘤病灶的代谢体积;高MTVwb阈值>54.0 cm3,高Dmax阈值>48.5 cm;联合评分0分(无危险因素)、1分(一个危险因素)、2分(两个危险因素);0分、1分、2分组的PFS分别为61.1%、43.5%、21.1%,OS分别为77.8%、54.3%、36.8%。

临床应用与阅片要点

  • 原文结论认为Dmax与MTVwb联合可进一步改善NSCLC的预后分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To explore the correlation between the tumor dissemination characteristic at 18F-fluoro-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) images and the outcome of first-line systemic therapy for stage IV non-small cell lung cancer (NSCLC).

MATERIALS AND METHODS: The current retrospective study included 101 NSCLC patients receiving first-line systemic therapy with baseline 18F-FDG PET/CT images available. The distance between the two lesions that were the farthest apart was defined as Dmax to calculate the tumor dissemination. The tumor metabolic volume (MTV) of the primary tumor and the MTV of the whole-body tumor lesions (MTVwb) were calculated using 18F-FDG PET/CT imaging. The Kaplan-Meier survival analyses and Cox predictive model were performed to assess the relationship between the parameters and survival.

RESULTS: Dmax and MTVwb were independent prognostic factors for overall survival (OS) (p = 0.019 and p = 0.011, respectively) and progression-free survival (PFS) (p = 0.043 and p = 0.009, respectively). Poor PFS and OS were associated with high MTVwb (>54.0 cm3) and high Dmax (>48.5 cm) (p = 0.006 and p = 0.008, respectively). When MTVwb and Dmax were combined, three risk groups were stratified with no (score 0), one (score 1), or two (score 2) factors (p < 0.001 for PFS, p < 0.001 for OS). The group with a score of 0 had a considerably longer PFS and OS than those who received a score of 1 or 2 (PFS: 61.1%, 43.5%, and 21.1%, respectively, OS: 77.8%, 54.3%, and 36.8%, respectively).

CONCLUSION: The combination of tumor dissemination characteristic (Dmax) and tumor burden (MTVwb) can further improve the prognosis stratification of NSCLC.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Tan, Zhang, Wang, et al. FDG PET/CT Tumor Dissemination Characteristic Predicts the Outcome of First-Line Systemic Therapy in Non-small Cell Lung Cancer. Acad Radiol. 2023. PMID: 37202226. doi:10.1016/j.acra.2023.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。